The 7 analysts offering 12-month price forecasts for Cue Biopharma Inc have a median target of 30.00, with a high estimate of 32.00 and a low estimate of 20.00. The median estimate represents a +233.33% increase from the last price of 9.00.
The current consensus among 7 polled investment analysts is to Buy stock in Cue Biopharma Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.37
Reporting Date Mar 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.